What are the typical dosing regimens for basal and bolus insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Typical Dosing Regimens for Basal and Bolus Insulin

Basal Insulin Dosing

For insulin-naive patients with type 2 diabetes, start with 10 units once daily or 0.1-0.2 units/kg body weight, administered at the same time each day. 1, 2

Initial Dosing by Clinical Scenario

Type 2 Diabetes - Standard Initiation:

  • Start with 10 units once daily OR 0.1-0.2 units/kg/day for patients with moderate hyperglycemia 1, 2, 3
  • Continue metformin (unless contraindicated) and possibly one additional non-insulin agent 1, 2
  • Administer at the same time daily (bedtime is most common) 2, 4

Type 2 Diabetes - Severe Hyperglycemia:

  • For HbA1c ≥9% or blood glucose ≥300-350 mg/dL, consider higher starting doses of 0.3-0.5 units/kg/day as total daily dose, split between basal and prandial insulin 1, 2, 5
  • For HbA1c 10-12% with symptomatic or catabolic features, initiate basal-bolus regimen immediately 1, 2

Type 1 Diabetes:

  • Total daily insulin requirement: 0.4-1.0 units/kg/day, with 0.5 units/kg/day typical for metabolically stable patients 2, 6
  • Divide approximately 50% as basal insulin and 50% as prandial insulin 2, 5
  • Higher doses needed during puberty, pregnancy, and acute illness (may exceed 1.0 units/kg/day) 2

Basal Insulin Titration Algorithm

Increase basal insulin systematically based on fasting glucose levels: 2

  • If fasting glucose 140-179 mg/dL: increase by 2 units every 3 days
  • If fasting glucose ≥180 mg/dL: increase by 4 units every 3 days
  • Target fasting plasma glucose: 80-130 mg/dL 1, 2
  • If hypoglycemia occurs without clear cause, reduce dose by 10-20% immediately 2, 5

Critical Threshold: When to Stop Escalating Basal Insulin

When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 1, 2

Clinical signs of "overbasalization" include: 2

  • Basal insulin dose >0.5 units/kg/day
  • Bedtime-to-morning glucose differential ≥50 mg/dL
  • Hypoglycemia episodes
  • High glucose variability despite adequate fasting glucose control

Bolus (Prandial) Insulin Dosing

When adding prandial insulin, start with 4 units of rapid-acting insulin before the largest meal OR 10% of the current basal dose. 1, 2

Indications for Adding Prandial Insulin

Add prandial insulin when: 1, 2

  • Basal insulin has been optimized (fasting glucose 80-130 mg/dL) but HbA1c remains above target after 3-6 months
  • Basal insulin dose approaches 0.5-1.0 units/kg/day without achieving glycemic goals
  • Significant postprandial glucose excursions persist despite adequate fasting control

Prandial Insulin Initiation Strategy

Stepwise Approach: 2, 5

  • Start with one prandial dose before the largest meal (typically dinner)
  • Use 4 units of rapid-acting insulin OR 10% of basal dose
  • Progress to two meals, then three meals as needed based on glucose patterns
  • Titrate each dose by 1-2 units or 10-15% every 3 days based on postprandial glucose readings

Rapid-Acting Insulin Options: 1, 6

  • Insulin lispro, aspart, or glulisine
  • Administer 0-15 minutes before meals
  • Preferred over regular insulin due to better postprandial control and lower hypoglycemia risk

Basal-Bolus Regimen for Severe Hyperglycemia

For patients requiring immediate basal-bolus therapy (HbA1c ≥10-12% with symptoms): 2, 5

  • Calculate total daily dose: 0.3-0.5 units/kg/day
  • Give 50% as basal insulin once daily
  • Give 50% as prandial insulin, divided among three meals
  • For high-risk patients (elderly >65 years, renal failure, poor oral intake), use lower doses of 0.1-0.25 units/kg/day 2, 5

Special Populations

Pediatric Type 2 Diabetes: 1

  • For youth with marked hyperglycemia (blood glucose ≥250 mg/dL, HbA1c ≥8.5%) without acidosis, start basal insulin while initiating metformin
  • Patients on basal insulin up to 1.5 units/kg/day who don't meet targets should transition to multiple daily injections with basal and premeal bolus insulin

Hospitalized Patients: 2, 7

  • For insulin-naive or low-dose patients: 0.3-0.5 units/kg/day total daily dose, with half as basal insulin
  • For patients on high-dose home insulin (≥0.6 units/kg/day): reduce total daily dose by 20% to prevent hypoglycemia
  • Continuous IV insulin infusion preferred for critically ill patients

Common Pitfalls to Avoid

Do not delay insulin therapy in patients not achieving glycemic goals - this is a critical error that prolongs poor glycemic control 1, 2

Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia - this leads to overbasalization with increased hypoglycemia risk and suboptimal control 2

Do not discontinue metformin when starting insulin - metformin should be continued unless contraindicated, as it reduces insulin requirements and provides complementary glucose-lowering effects 1, 2

Do not rely solely on sliding scale insulin - scheduled basal-bolus regimens are superior to correction insulin alone 2, 7

Do not wait longer than 3 days between basal insulin adjustments in stable patients - this unnecessarily prolongs time to achieve glycemic targets 2


Monitoring Requirements

Daily fasting blood glucose monitoring is essential during titration 1, 2

Assess insulin adequacy at every clinical visit, looking for signs of overbasalization 2

Check HbA1c every 3 months during intensive titration 1, 2

Adjust both basal and prandial insulin based on self-monitoring of blood glucose levels - fasting glucose guides basal insulin, while pre-meal and postprandial glucose guide prandial insulin 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Type 2 Diabetes Mellitus: Outpatient Insulin Management.

American family physician, 2018

Guideline

Basal-Bolus Insulin Preparation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Research

Insulin Therapy in Hospitalized Patients.

American journal of therapeutics, 2020

Related Questions

When should insulin be used in patients with hyperglycemia?
Can insulin be administered to a patient who is fasting?
What is the most appropriate treatment for a 17-year-old male with type 2 diabetes mellitus (T2DM), presenting with hyperglycemia, polyuria, polydipsia, and significant weight loss, after discontinuing metformin (Metformin) therapy 6 months prior?
What is the most appropriate medication for an 18-year-old man presenting with hyperglycemia (elevated blood glucose), nausea, frequent urination, unintentional weight loss, hypotension (low blood pressure), tachycardia (rapid heart rate), and dry oral mucosa?
What is the best course of action for a patient with persistent hyperglycemia despite being on insulin?
What is the role of Magnetic Resonance (MR) elastography in evaluating treatment response of liver tumors after Microwave Ablation (MWA)?
What is the recommended prevention and management for Subacute Sclerosing Panencephalitis (SSPE) in individuals aged 5 years or older after measles infection?
What is the initial approach for a patient presenting with elevated Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), and alkaline phosphatase along with fever?
Should metronidazole be taken before or after food?
Is the risk of Subacute Sclerosing Panencephalitis (SSPE) from measles infection negligible in individuals over 5 years old?
Is it reasonable to stop glipizide (a sulfonylurea) in a patient with well-controlled diabetes and a hemoglobin A1C (HbA1C) of 5.8 who is also taking metformin (a biguanide) and Mounjaro (tirzepatide) until the next HbA1C check?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.